A Study of Baricitinib (LY3009104) in Children and Adolescents With Atopic Dermatitis
Condition: Atopic Dermatitis · Sponsor: Eli Lilly and Company
About this study
The reason for this study is to see if the study drug called baricitinib works and is safe in children and teenage participants with atopic dermatitis.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (78)
| Instituto de Neumonología Y Dermatología | Capital Federal, Buenos Aires, Argentina | — |
| Centro de Investigaciones Metabólicas (CINME) | Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina | — |
| Fundacion CIDEA | Buenos Aires, Ciudad Autonoma Buenos Aires, Argentina | — |
| Fundación Respirar | Buenos Aires, Argentina | — |
| The Children's Hospital at Westmead | Westmead, New South Wales, Australia | — |
| Veracity Clinical Research | Woolloongabba, Queensland, Australia | — |
| Royal Children's Hospital | Melbourne, Victoria, Australia | — |
| Medizinische Universität Wien | Vienna, State of Vienna, Austria | — |
| Sozialmedizinisches Zentrum Ost/Donauspital | Vienna, State of Vienna, Austria | — |
| Medizinische Universität Graz | Graz, Styria, Austria | — |
| Hospital de Clinicas de Porto Alegre | Porto Alegre, Rio Grande do Sul, Brazil | — |
| Faculdade de Medicina do ABC | Santo André, São Paulo, Brazil | — |
+ 66 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03952559